CVS Health Corp (CVS)

CVS (NYSE:Health Services) EQUITY
$76.51
pos +0.56
+0.74%
Today's Range: 75.94 - 76.61 | CVS Avg Daily Volume: 6,475,300
Last Update: 05/26/17 - 2:50 PM EDT
Volume: 2,639,128
YTD Performance: -3.75%
Open: $76.00
Previous Close: $75.95
52 Week Range: $69.30 - $98.67
Oustanding Shares: 1,018,795,398
Market Cap: 77,856,344,315
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 10 12
Moderate Buy 1 1 1 1
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.83 1.83 1.83 1.75
Latest Dividend: 0.50
Latest Dividend Yield: 2.62%
Dividend Ex-Date: 04/19/17
Price Earnings Ratio: 15.95
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
15.95 16.00 29.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.79% -22.14% -1.52%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.80 0.40 0.12
Net Income 1.50 0.20 0.05
EPS 6.00 0.30 0.09
Earnings for CVS:
EBITDA 12.81B
Revenue 177.53B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.31 $1.63 $5.87 $6.35
Number of Analysts 21 23 23 23
High Estimate $1.33 $1.69 $5.90 $6.50
Low Estimate $1.29 $1.51 $5.82 $6.00
Prior Year $1.32 $1.64 $5.84 $5.87
Growth Rate (Year over Year) -0.83% -0.56% 0.44% 8.32%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Update
Apr 28, 2017 | 9:11 AM EDT
Tigress initiated coverage of CVS with a "Buy" rating. 
The wide miss in the jobs number was just the latest data point confirming the slowdown of the domestic economy.
If you're waiting for positive quarterly comparisons, you'll miss the opportunity.
Two different messages are likely to emerge from Target's annual meeting with the financial community.
Bearish
Feb 02, 2017 | 6:57 AM EST
CVS was downgraded from Outperform to Neutral, Robert Baird said. $77 price target. Current fundamentals are not good.
Demographics will continue to favor health-care and pharmaceutical companies.
As border tax gets shaky, retailers show signs of life.
Value stocks will extend their outperformance over growth stocks that began last year.
During a week that brought the long-awaited Fed interest rate increase, we exited one portfolio position.

How to Create Your Own Bargain Real Money Pro($)

CVS Health is an example of using LEAP options to manufacture a great entry point.

Columnist Conversations

A big THANK YOU to all the men and women in uniform this weekend, and for those who served and paid the ultima...
View Chart »  View in New Window » View Chart » 

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.